Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06636006

Effects of Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia in University Students With Insomnia Complaints

Led by Universidade Federal de Goias · Updated on 2026-04-24

50

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of aerobic exercise compared to digital cognitive behavioral therapy for insomnia (CBT-I) in university students who have complaints of insomnia. The study aims to see if aerobic exercise can produce similar improvements as digital CBT-I in reducing insomnia severity and improving sleep quality, as well as reducing symptoms of depression, anxiety, and stress. This is a clinical trial sponsored by Universidade Federal de Goias with randomized participant groups. Participants will be divided into two groups: one group will engage in aerobic exercise consisting of three outdoor walking sessions per week, each lasting 50 continuous minutes at moderate intensity, for 7 weeks. These sessions will be supervised and recorded by a researcher. The second group will participate in three weekly sessions of digital CBT-I via the Vigilantes do Sono® app, which follows an approved therapeutic protocol. During the study, participants will complete self-administered questionnaires to assess insomnia severity, sleep quality, cognitive and somatic arousal before sleep, and symptoms of depression, anxiety, and stress both at the start and after 7 weeks of intervention. Additional evaluations include physical assessments, sleep diaries, physical activity levels, and sedentary behavior. Researchers will monitor adherence to the interventions and collect data to compare outcomes between the two groups.

CONDITIONS

Brief Title

Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be 18 years old or older
  • Have an insomnia severity index score greater than 8
  • Be physically inactive according to the IPAQ questionnaire
Not Eligible

You will not qualify if you...

  • Non-adherence to intervention protocols
  • Absence or incomplete answers in the questionnaires or evaluation methods of the study
  • Being a shift worker

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 7 weeks

Participants engage in one of two treatment options: three weekly sessions of aerobic exercise lasting 50 minutes at moderate intensity, or three weekly sessions of digital cognitive behavioral therapy for insomnia through a specialized app. This treatment lasts for 7 weeks.

Three sessions per week

Trial Site Locations

Total: 1 location

1

Maria Tereza

Jatai, Goiás, Brazil, 75801-615

Actively Recruiting

Loading map...

Research Team

G

Giselle Soares Passos, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Usability, Acceptability, and Preliminary Effectiveness of a...

Insomnia Chronic

Actively Recruiting

1 location

Effectiveness of Ba Duan Jin Exercise on Chronic Insomnia wi...

Mind-Body Therapies

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index.

Alessandra Naimaier Bertolazi, Simone Chaves Fagondes, Leonardo Santos Hoff...

https://pubmed.ncbi.nlm.nih.gov/21145786